Trial intelligence / Profile preview

HCG for children with undescended testis

IRCT20171127037646N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Dec 2019
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label trial of human chorionic gonadotropin in cryptorchidism (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Drug efficacy, Rate of decline and 2 more. Started Dec 2019; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

cryptorchidism

Beyond the preview

Go deeper on IRCT20171127037646N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171127037646N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call